Precancerous conditions

• Health & Medicine

New oesophageal cancer screening trial begins testing the capsule sponge

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

28 November 2024

• Science & Technology
• Health & Medicine

Oesophageal cancer awareness month: 4 articles on the latest in prevention and treatment

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

9 February 2024

• Health & Medicine
• Science & Technology

Can a capsule sponge change how we diagnose oesophageal cancer?

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

11 January 2024

• Science & Technology

How patient data is helping beat cancer

Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs. Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs.

21 November 2023

• Science & Technology

Studying precancer to prevent cancer: ecDNA in Barrett's oesophagus

Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous. Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous.

23 October 2023

• Science & Technology

How clues from crystals might help us prevent the overtreatment of DCIS

New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future New research may have found a way we can predict which cases of DCIS could develop into invasive breast cancer and thus require treatment, reducing the burden of overtreatment in future

20 June 2023

• Science & Technology
• Health & Medicine

Genetic link to Barrett's oesophagus identified for first time

UK scientists have discovered the genetic basis for why some people are more at risk of developing Barrett's oesophagus, a condition that increases the risk of oesophageal cancer. UK scientists have discovered the genetic basis for why some people are more at risk of developing Barrett's oesophagus, a condition that increases the risk of oesophageal cancer.

10 September 2012

• Health & Medicine

Study suggests oesophageal cancer 'less common than previously thought' in people with Barrett's oesophagus

In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates. In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates.

13 October 2011

Blocking cancer cell's energy generator could lead to new targeted treatments

CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones. CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

17 August 2011

• Health & Medicine

60-year-old drug shows new promise for inherited cancer

CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday). CANCER RESEARCH UK-funded scientists have shown that an early chemotherapy drug invented in the 1940s has the potential to work against a genetic fault called HNPCC* which is linked to bowel and other cancers. The results are published in EMBO Molecular Medicine** today, (Thursday).

27 August 2009

Doctors trial the coil to prevent womb cancer

NEW research in Yorkhill Hospital and Glasgow Royal Infirmary is investigating whether a form of the contraceptive coil can stop women from developing womb cancer. NEW research in Yorkhill Hospital and Glasgow Royal Infirmary is investigating whether a form of the contraceptive coil can stop women from developing womb cancer.

10 June 2008

• Health & Medicine

Preventing bowel cancer in high risk families

Bowel cancer rates could be reduced by up to 80 per cent in people with a moderate family history of the disease by screening with colonoscopy, according to new research published in the British Medical Journal. Bowel cancer rates could be reduced by up to 80 per cent in people with a moderate family history of the disease by screening with colonoscopy, according to new research published in the British Medical Journal.

25 October 2005